Risk factors for ovarian metastasis following curative resection of gastric adenocarcinoma.
Noe K. Kim , Hark K. Kim , Byung J. Park , Min S. Kim
Cancer 85 ( 7) 1490 -1499
34
1999
Cyclin E overexpression as an independent risk factor of visceral relapse in breast cancer.
Hark K. Kim , In-A. Park , Dae S. Heo , Dong-Y. Noh
Ejso 27 ( 5) 464 -471
43
2001
Prognostic Factors of Krukenberg's Tumor
Hark K. Kim , Dae S. Heo , Yung-J. Bang , Noe K. Kim
Gynecologic Oncology 82 ( 1) 105 -109
69
2001
Concurrent versus sequential administration of CMF chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer.
Eui Kyu Chie , Yung-Jue Bang , Seock-Ah Im , Do-Youn Oh
Tumori 97 ( 3) 280 -285
5
2011
Efficacy of platinum-based chemotherapy after cranial radiation in patients with brain metastasis from non-small cell lung cancer
Dae Seog Heo , Yung-Jue Bang , Tak Yun , Keun-Wook Lee
Oncology Reports 14 ( 1) 207 -211
21
2005
Immunohistochemical Features Associated with Sensitivity to Lapatinib-plus-Capecitabine and Resistance to Trastuzumab in HER2-positive Breast Cancer
Yung-Jue Bang , Hyesil Seol , Seock-Ah Im , Wonshik Han
Anticancer Research 34 ( 8) 4275 -4280
6
2014
Gastric Epithelial Reactive Oxygen Species Prevent Normoxic Degradation of Hypoxia-inducible Factor-1α in Gastric Cancer Cells
Yung-Jue Bang , Noe Kyeong Kim , Choon-Taek Lee , Jong-Wan Park
Clinical Cancer Research 9 ( 1) 433 -440
149
2003
Cyclooxygenase-2 and p53 Expressions in Endometrial Cancer
Yung-Jue Bang , Noh-Hyun Park , Yong-Sang Song , Yong-Tark Jeon
Cancer Epidemiology, Biomarkers & Prevention 13 ( 9) 1538 -1542
36
2004
The Prognostic Significance of HER2 Positivity for Advanced Gastric Cancer Patients Undergoing First-line Modified FOLFOX-6 Regimen
Jin Won Kim , Seock-Ah Im , Miso Kim , Yongjun Cha
Anticancer Research 32 ( 4) 1547 -1553
24
2012
Combination Chemotherapy with S-1 and Platinum in Advanced Hepatocellular Carcinoma
Yung-Jue Bang , Nam-Joon Yi , Seock-Ah Im , Jung-Hwan Yoon
Anticancer Research 30 ( 12) 5245 -5250
4
2010
Chemopreventive effects of a specific COX-2 inhibitor (Celecoxib) and a novel HDAC inhibitor (SK-7041) on azoxymethane-initiated and dextran sulfate sodium-promoted mouse colon carcinogenesis
Yung-Jue Bang , Young-Joon Surh , Marie Yeo , Jeong-Sang Lee
Cancer Research 65 580 -580
2005
A multivariate analysis of prognostic factors in colorectal cancer
Dong-Wan KIM , Min-Hee RYU , Tae-You KIM , Dae-Seog HEO
The Korean Journal of Internal Medicine 64 ( 3) 268 -274
7
2003
Bone Marrow Immunoscintigraphy for the Detection of Skeletal Metastasis in Malignant Tumors: A Comparison with $^{99m}Tc$-MDP Bone Scan
Yung-Jue Bang , Chang-Soon Koh , Byoung-Kook Kim , Hong-Keun Chung
The Korean Journal of Nuclear Medicine 28 ( 1) 89 -97
1
1994
Combination chemotherapy of irinotecan combined with bolus 5-fluorouracil, continuous infusion 5-fluorouracil, and high dose leucovorin every two weeks in recurrent or metastatic colorectal cancer.
Yung-Jue Bang , In-Sil Choi , Sook-Ryun Park , Se-Hoon Lee
The Korean Journal of Internal Medicine 64 ( 4) 452 -458
4
2003
The distinct signatures of VEGF and soluble VEGFR2 increase prognostic implication in gastric cancer.
Yung-Jue Bang , Seock-Ah Im , Do-Youn Oh , Kyung-Hun Lee
American Journal of Cancer Research 5 ( 11) 3376 -3388
9
2015
Chemoradiotherapy for Extrahepatic Bile Duct Cancer with Gross Residual Disease after Surgery
Eui Kyu Chie , Yung-Jue Bang , Seock-Ah Im , Do-Youn Oh
Anticancer Research 34 ( 11) 6685 -6690
2
2014
Accomplishments in 2008 in the management of localized gastric cancer.
Yung-Jue Bang , Alicia Okines , David Cunningham
Gastrointestinal Cancer Research : GCR 3
1
2009
Progression-Free Survival (PFS) by Blinded Independent Central Review (BICR) and Updated Overall Survival (OS) of Sunitinib versus Placebo for Patients with Progressive, Unresectable, Well Differentiated Pancreatic Neuroendocrine Tumor (NET)
Catherine Lombard-Bohas , Eric Van Cutsem , Joel Picus , Guy Van Hazel
Pancreas 41 ( 2) 350 -350
3
2012
Involvement of nuclear factor kappa B in the upregulation of cyclooxygenase-2 expression by HPV 16 E5 through EGFR and its signaling pathways
Yung-Jue Bang , Yong-Sang Song , Jung-Min Oh , Yung-Sung Juhnn
Cancer Research 67 4260 -4260
2007
RhoGAP DLC-1 tumor suppression and aberrant Rho GTPase activation in lung cancer
Adam T. Shutes , Rudolph L. Juliano , Channing J. Der , Kevin D. Healy
Cancer Research 66 970 -970
2
2006